Report Finds Warning Letters Down, But FDA Says Enforcement Is Still Strong

A report by a leading House Democrat shows that the number of warning letters issued by FDA dropped more than 50% over the last five years, but FDA says the figures don't necessarily mean the agency has grown lax in its enforcement

More from Archive

More from Medtech Insight